openPR Logo
Press release

Global Peptides and Heparin Market Expected to Deliver Dynamic Progression until 2026|| Global key companies are Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd

01-28-2019 02:15 PM CET | Health & Medicine

Press release from: Fact.MR

Global Peptides and Heparin Market Expected to Deliver Dynamic

Peptides are amino acids’ short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.

Click here for Free Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=378

A new report by FactMR projects the global peptide and heparin market to reflect an impressive expansion during the forecast period, 2017 to 2026. Revenues from the market are estimated to exceed US$ 34,000 Mn by 2026-end.

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

View Full Report with Table of Content: https://www.factmr.com/report/378/peptides-heparin-market

Key Research Findings from FactMR’s Report on Peptide and Heparin Market

Oral route of administration will remain preferred for peptide and heparin
Cancer will continue to be the dominant indication segment in the market, in terms of revenues
Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin
Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

Make an inquiry for purchasing this report: https://www.factmr.com/checkout/378/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://westminsternewsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptides and Heparin Market Expected to Deliver Dynamic Progression until 2026|| Global key companies are Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd here

News-ID: 1538637 • Views:

More Releases from Fact.MR

System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: Fact.MR Report
System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: …
The global system integration market is estimated to have a valuation of US$ 401.8 billion in 2024. Projections put the CAGR of the market for the 2024 to 2034 period at a remarkable 18.7%. The market's growth over the forecast period is set to inflate significantly, reaching a projected value of US$ 2,236.6 billion by 2034. The System Integration Industry sales study offers a comprehensive analysis on diverse features including production
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fact.MR Report
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fac …
Bromelain market size is pegged at US$ 27.3 million for 2024. Worldwide demand for bromelain is predicted to increase at a robust CAGR of 7.5% and reach a market value of US$ 56.2 million by the end of 2034. The Bromelain Industry sales study offers a comprehensive analysis on diverse features including production capacities, Bromelain demand, product developments, sales revenue generation and Bromelain market outlook across the globe. market research report by
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of 2034: Fact.MR Report
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of …
The global writing instrument market size is calculated at US$ 14.28 billion for 2024 and is projected to reach US$ 20.54 billion by 2034-end. Worldwide demand for writing instruments is projected to expand at a CAGR of 3.7% from 2024 to 2034. The Writing Instrument Industry sales study offers a comprehensive analysis on diverse features including production capacities, Writing Instrument demand, product developments, sales revenue generation and Writing Instrument market outlook
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach US$ 19.9 Billion by 2033
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach U …
The worldwide data mining and visualization market in the life sciences sector is projected to exceed $8.3 billion by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.1%, reaching $19.9 billion by 2033. In 2022, revenue from data mining and visualization in the life sciences amounted for 7% of the total data analytics market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗢𝗳 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=459 Using data mining and visualization

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug